Independent Franchise Partners
US Equity Fund
Independent Franchise Partners Accenture plc stake
total: 60
US Equity Fund ACN trades
- Total transactions:
- 13
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 10
- Held since:
- 2019 Q3
- Held for:
- 13 quarters
- Latest activity:
- 2022 Q4
According to 2026 Q1 report, Independent Franchise Partners doesn't hold any Accenture plc (ACN) shares. To date, the estimated cost basis is nearly $192.52 for "buy" trades and estimated average "sell" price is $254.47. US Equity Fund first purchased ACN in 2019 Q3, initially acquiring 529,488 shares. Since the initial investment in Accenture plc (ACN), US Equity Fund has made 12 more transactions.
When did Independent Franchise Partners sell Accenture plc (ACN)?
Independent Franchise Partners sold off the entire Accenture plc (ACN) position in 2022 Q4.
When did Independent Franchise Partners buy Accenture plc (ACN)?
Independent Franchise Partners first invested in Accenture plc (ACN) in 2019 Q3 at the reported quarter-end price of $192.35 per share.
What's the cost basis of US Equity Fund's ACN stake?
The estimated cost basis for Accenture plc (ACN) stake is around $192.52 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $192.52
- Weighted AVG sell price:
- $254.47
Independent Franchise Partners's historical trades in Accenture plc
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q4
|
0.00%
|
0
|
$257.30
|
|
-100% (-27,537)
|
-0.48%
|
|
2022 Q3
|
0.48%
|
27,537
|
$257.30
|
$7,085,270
|
-64.15% (-49,267)
|
-0.8%
|
|
2022 Q2
|
1.34%
|
76,804
|
$277.65
|
$21,324,631
|
-2.27% (-1,780)
|
-0.03%
|
|
2022 Q1
|
1.41%
|
78,584
|
$337.23
|
$26,500,882
|
-10.66% (-9,377)
|
-0.15%
|
|
2021 Q4
|
1.75%
|
87,961
|
$414.55
|
$36,464,233
|
-29.84% (-37,415)
|
-0.78%
|
|
2021 Q3
|
2.01%
|
125,376
|
$319.92
|
$40,110,290
|
-40.04% (-83,711)
|
-1.33%
|
|
2021 Q2
|
3.05%
|
209,087
|
$294.79
|
$61,636,757
|
-22.79% (-61,702)
|
-0.94%
|
|
2021 Q1
|
3.89%
|
270,789
|
$276.25
|
$74,805,461
|
+0.40% (+1,076)
|
+0.02%
|
|
2020 Q4
|
3.82%
|
$261.21
|
-0.61% (-1,655)
|
|||
|
2020 Q3
|
3.73%
|
$225.99
|
-2.40% (-6,667)
|
|||
|
2020 Q1
|
3.41%
|
$163.26
|
-22.30% (-79,795)
|
|||
|
2019 Q4
|
4.75%
|
$210.57
|
-32.42% (-171,658)
|
|||
|
2019 Q3
|
5.03%
|
$192.35
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.